aifleet is the first full-stack tech-enabled trucking company rebuilding global freight delivery to benefit truck drivers, the planet, and our economy. With our AI technology, our trucks achieve higher utilization and more revenue than the industry average, allowing us to provide drivers with greater rewards and unique benefits on and off the road.
Bionaut Labs revolutionizes the treatment of central nervous system disorders with its precision medicine treatment modality. By creating a new medical modality of remote-controlled micro-robots called Bionauts, the company can transform the way the biopharmaceutical industry develops treatments, allowing them to engineer the therapeutic index for efficacy and maintain safety. Bionaut Labs is focused on helping patients suffering from debilitating brain diseases who have few available treatment options. The anatomical targeting capabilities of the Bionaut platform make new therapeutics technologies such as gene therapy, CRISPR-Cas9, and oncolytic viruses viable in challenging clinical settings.
CellVoyant is an artificial intelligence biotechnology company with a mission to create novel stem cell-based therapies for chronic diseases. Their technology uses AI-first live cell imaging to predict and optimize stem cell differentiation, to controllably manufacture any cell and tissue in the body at scale.
Compound is an open-source interest rate protocol that unlocks new financial applications for developers. Its protocol is a widely used system built on Ethereum, with thousands of users, and dozens of applications integrating Compound. Compound offers a web interface that adjusts money market interest rates based on asset-specific supply and demand. Compound was founded on 2017 and is headquartered in San Francisco, California.